ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
13 announcements with these filters
Hikal Ltd held its 38th AGM on September 23, 2026, approving financial statements, director appointments, remuneration revisions, and declaring a total dividend of ₹0.60 per share.
Hikal has begun commercial production at its new cGMP Panoli facility, entering Personal Care manufacturing. First batches of UV filters and skincare ingredients are now being supplied to global customers.
Hikal Ltd has filed its Business Responsibility and Sustainability Report for FY 2025-26, fulfilling regulatory compliance requirements under SEBI (LODR) Regulations, 2015.
Hikal Limited has submitted its Annual Report for FY 2025-26 and the Notice of its 38th Annual General Meeting to the stock exchanges.
Hikal Ltd has scheduled its 38th Annual General Meeting for September 23, 2026. The company fixed September 04, 2026, as the record date for final dividend eligibility.
Hikal Limited has appointed Mr. Sameer Hiremath as Chairman and Managing Director for five years. The appointment is effective from October 1, 2026, subject to shareholder approval.
Hikal reported Q1 FY27 revenue of Rs 403 Cr with 9.2% EBITDA margin. Results show recovery post-regulatory disruption, driven by Pharma and Animal Health scaling.
Hikal Ltd. reported Q1 FY27 revenue of ₹403 Crore, with EBITDA of ₹37 Crore. The release details segment performance and operational updates for the quarter.
Hikal reported Q1FY27 revenue of ₹403 Cr, up 6% YoY. Focus remains on pharma remediation and commissioning the Panoli facility for Personal Care.
Hikal Ltd reported revenue from operations of ₹402.8 Cr (+5.9% YoY) and a net loss of ₹7.4 Cr for Q1 FY27.
Hikal Ltd. scheduled a board meeting for August 06, 2026, to consider and approve standalone and consolidated unaudited financial results for the June quarter.
Hikal Ltd. has been awarded the EcoVadis Gold Medal for its sustainability performance, placing the company in the top 5% of companies assessed by EcoVadis globally.
Hikal Ltd filed its quarterly shareholding pattern. The disclosure includes a conversion of Castilia Life Sciences Private Limited into an LLP.